Tentalabbet

8BKG47 · 6 credits · Basic level (G2X) · Medicinsk biologi

Project Course: Drug Development

Active · next start VT 2027

100%

passed the latest regular sitting

47CE · 17 Jun 2026 · 41 students

100%

passed the regular sittings, all sittings over the last 5 years

47CE · 207 students

This module only reports passing results, so the pass rate does not show how many did not pass.

Part of 1 programme

Other module

47CE Compulsory elements

  • G

Main rounds

100% passed · 207 students

  • 100%41
  • 100%47
  • 100%45
  • 100%34
  • 100%40

Later rounds

No sittings with at least 5 students.

    Show small sittings (2)

    Sittings with fewer than 5 students, often credit transfers or special sittings. They are not part of any figure on this page.

    • 100%2
    • 100%1

    Other modules

    Partial exams, hand-ins and labs. They are not part of the figures at the top.

    Other module

    47PR Project report and assignments

    • G

    Main rounds

    100% passed · 207 students

    • 100%41
    • 100%47
    • 100%45
    • 100%34
    • 100%40

    Later rounds

    No sittings with at least 5 students.

      Show small sittings (3)

      Sittings with fewer than 5 students, often credit transfers or special sittings. They are not part of any figure on this page.

      • 100%1
      • 100%1
      • 100%1

      About the course

      Aim

      Knowledge and understanding

      Having completed the course, the student is expected to be able to:

      • Describe the principles of how low molecular weight substances that increase or decrease the activity of target molecules (agonists/antagonists) can be identified through screening
      • Describe the principles of in vitro high-throughput screening and cell-based screening
      • Demonstrate a basic understanding of desirable properties in small molecules for further development
      • Describe the principles of protein production in prokaryote and eukaryote systems for further therapeutic use

      Skills and abilities

      On completion of the course, the student shall be able to:

      • Apply laboratory methods of drug screening
      • Critically appraise the principles of assay development (sensitivity and specificity)
      • Compile, analyse and present results orally and in writing

      Judgement ability and approach

      On completion of the course, the student shall be able to:

      • Critically appraise and evaluate knowledge within the field of drug development from an academic, ethical and social perspective.

      Content

      The course is a basic course in drug development. It includes practical elements in which collections of small molecules are screened to determine pharmacological properties on cell activity. Manufacturing of recombinant proteins is used to illustrate the principles of the production of protein drugs. The course also aims to create an understanding of the principles of lead optimisation within drug development.

      Examiner
      Padraig D´arcy
      Main field of study
      Medicinsk biologi
      Syllabus on Studieinfo ↗